Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-26

Clinical Trial Update: Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of phenazopyridine hydrochloride 200 mg tablets for short-term relief in women with uncomplicated urinary tract infe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phenazopyridine hydrochloride (phenazopyridine hydrochloride)

Snippet

Sponsor: Amneal Pharmaceuticals, LLC | Conditions: Uncomplicated Urinary Tract Infections | Phase 3 | Status: COMPLETED